Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer.

Jennifer K PlichtaSamantha M ThomasDaniel F Hayes Mariana Chavez Mac GregorKimberly AllisonJennifer de Los SantosAmy M FowlerArmando E GiulianoPriyanka Sharma Benjamin D SmithElizabeth van EyckenStephen B Edge Gabriel N Hortobagyi

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)

Our findings regarding the heterogeneity in outcomes for patients with dnMBC could guide future revisions of the current American Joint Committee on Cancer staging guidelines for patients with newly diagnosed stage IV disease. Our findings should be independently confirmed.

Keyphrases

metastatic breast cancer
newly diagnosed
lymph node
pet ct
papillary thyroid
single cell
current status
clinical practice
squamous cell carcinoma
metabolic syndrome
insulin resistance